Request for Covid-19 Impact Assessment of this Report
The United States Gamma-aminobutyric Acid (GABA) Receptor Agonist market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market, reaching US$ million by the year 2028. As for the Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Gamma-aminobutyric Acid (GABA) Receptor Agonist players cover Sanofi, Mylan N.V., Teva Pharmaceutical Industries, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gamma-aminobutyric Acid (GABA) Receptor Agonist market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Oral
Parenteral
Intrathecal
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Specialty Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries
Novartis
Aytu BioScience
Dr. Reddy’s Laboratories
Endo Pharmaceuticals
Lupin
Johnson & Johnson Services
Lannett
Sun Pharmaceutical Industries
Cipla
Aurobindo Pharma
Zydus Cadila
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2017-2028
2.1.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Segment by Type
2.2.1 Oral
2.2.2 Parenteral
2.2.3 Intrathecal
2.2.4 Others
2.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type
2.3.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Type (2017-2022)
2.4 Gamma-aminobutyric Acid (GABA) Receptor Agonist Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Others
2.5 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application
2.5.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Application (2017-2022)
3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Player
3.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Players
3.1.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Players (2020-2022)
3.1.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Players (2020-2022)
3.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gamma-aminobutyric Acid (GABA) Receptor Agonist by Regions
4.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Regions (2017-2022)
4.2 Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth (2017-2022)
4.3 APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth (2017-2022)
4.4 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth (2017-2022)
4.5 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth (2017-2022)
5 Americas
5.1 Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022)
5.2 Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022)
5.3 Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2017-2022)
6.2 APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022)
6.3 APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist by Country (2017-2022)
7.2 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022)
7.3 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist by Region (2017-2022)
8.2 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022)
8.3 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecast by Regions (2023-2028)
10.1.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecast by Regions (2023-2028)
10.1.2 Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecast
10.1.3 APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecast
10.1.4 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecast
10.1.5 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecast
10.2 Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecast by Country (2023-2028)
10.2.1 United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.2.2 Canada Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.2.3 Mexico Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.2.4 Brazil Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.3 APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecast by Region (2023-2028)
10.3.1 China Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.3.2 Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.3.3 Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.3.4 Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.3.5 India Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.3.6 Australia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.4 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecast by Country (2023-2028)
10.4.1 Germany Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.4.2 France Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.4.3 UK Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.4.4 Italy Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.4.5 Russia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.5 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecast by Region (2023-2028)
10.5.1 Egypt Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.5.2 South Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.5.3 Israel Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.5.4 Turkey Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.5.5 GCC Countries Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast
10.6 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecast by Type (2023-2028)
10.7 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.1.3 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Mylan N.V.
11.2.1 Mylan N.V. Company Information
11.2.2 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.2.3 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Mylan N.V. Main Business Overview
11.2.5 Mylan N.V. Latest Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Information
11.3.2 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.3.3 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Teva Pharmaceutical Industries Main Business Overview
11.3.5 Teva Pharmaceutical Industries Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.4.3 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Aytu BioScience
11.5.1 Aytu BioScience Company Information
11.5.2 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.5.3 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Aytu BioScience Main Business Overview
11.5.5 Aytu BioScience Latest Developments
11.6 Dr. Reddy’s Laboratories
11.6.1 Dr. Reddy’s Laboratories Company Information
11.6.2 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.6.3 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Dr. Reddy’s Laboratories Main Business Overview
11.6.5 Dr. Reddy’s Laboratories Latest Developments
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Company Information
11.7.2 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.7.3 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Endo Pharmaceuticals Main Business Overview
11.7.5 Endo Pharmaceuticals Latest Developments
11.8 Lupin
11.8.1 Lupin Company Information
11.8.2 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.8.3 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Lupin Main Business Overview
11.8.5 Lupin Latest Developments
11.9 Johnson & Johnson Services
11.9.1 Johnson & Johnson Services Company Information
11.9.2 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.9.3 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Johnson & Johnson Services Main Business Overview
11.9.5 Johnson & Johnson Services Latest Developments
11.10 Lannett
11.10.1 Lannett Company Information
11.10.2 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.10.3 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Lannett Main Business Overview
11.10.5 Lannett Latest Developments
11.11 Sun Pharmaceutical Industries
11.11.1 Sun Pharmaceutical Industries Company Information
11.11.2 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.11.3 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sun Pharmaceutical Industries Main Business Overview
11.11.5 Sun Pharmaceutical Industries Latest Developments
11.12 Cipla
11.12.1 Cipla Company Information
11.12.2 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.12.3 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Cipla Main Business Overview
11.12.5 Cipla Latest Developments
11.13 Aurobindo Pharma
11.13.1 Aurobindo Pharma Company Information
11.13.2 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.13.3 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Aurobindo Pharma Main Business Overview
11.13.5 Aurobindo Pharma Latest Developments
11.14 Zydus Cadila
11.14.1 Zydus Cadila Company Information
11.14.2 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
11.14.3 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Zydus Cadila Main Business Overview
11.14.5 Zydus Cadila Latest Developments
12 Research Findings and Conclusion
Table 1. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Parenteral
Table 4. Major Players of Intrathecal
Table 5. Major Players of Others
Table 6. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Type (2017-2022)
Table 9. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Application (2017-2022)
Table 12. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Player (2020-2022)
Table 14. Gamma-aminobutyric Acid (GABA) Receptor Agonist Key Players Head office and Products Offered
Table 15. Gamma-aminobutyric Acid (GABA) Receptor Agonist Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Regions (2017-2022)
Table 20. Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Country (2017-2022)
Table 22. Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Type (2017-2022)
Table 24. Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Application (2017-2022)
Table 26. APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Region (2017-2022)
Table 28. APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Type (2017-2022)
Table 30. APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Application (2017-2022)
Table 32. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Country (2017-2022)
Table 34. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Type (2017-2022)
Table 36. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Gamma-aminobutyric Acid (GABA) Receptor Agonist
Table 45. Key Market Challenges & Risks of Gamma-aminobutyric Acid (GABA) Receptor Agonist
Table 46. Key Industry Trends of Gamma-aminobutyric Acid (GABA) Receptor Agonist
Table 47. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share Forecast by Application (2023-2028)
Table 53. Sanofi Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 54. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 55. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Sanofi Main Business
Table 57. Sanofi Latest Developments
Table 58. Mylan N.V. Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 59. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 60. Mylan N.V. Main Business
Table 61. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Mylan N.V. Latest Developments
Table 63. Teva Pharmaceutical Industries Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 64. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 65. Teva Pharmaceutical Industries Main Business
Table 66. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Teva Pharmaceutical Industries Latest Developments
Table 68. Novartis Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 69. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 70. Novartis Main Business
Table 71. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Novartis Latest Developments
Table 73. Aytu BioScience Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 74. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 75. Aytu BioScience Main Business
Table 76. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Aytu BioScience Latest Developments
Table 78. Dr. Reddy’s Laboratories Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 79. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 80. Dr. Reddy’s Laboratories Main Business
Table 81. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Dr. Reddy’s Laboratories Latest Developments
Table 83. Endo Pharmaceuticals Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 84. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 85. Endo Pharmaceuticals Main Business
Table 86. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Endo Pharmaceuticals Latest Developments
Table 88. Lupin Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 89. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 90. Lupin Main Business
Table 91. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Lupin Latest Developments
Table 93. Johnson & Johnson Services Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 94. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 95. Johnson & Johnson Services Main Business
Table 96. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Johnson & Johnson Services Latest Developments
Table 98. Lannett Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 99. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 100. Lannett Main Business
Table 101. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Lannett Latest Developments
Table 103. Sun Pharmaceutical Industries Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 104. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 105. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. Sun Pharmaceutical Industries Main Business
Table 107. Sun Pharmaceutical Industries Latest Developments
Table 108. Cipla Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 109. Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 110. Cipla Main Business
Table 111. Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Cipla Latest Developments
Table 113. Aurobindo Pharma Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 114. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 115. Aurobindo Pharma Main Business
Table 116. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 117. Aurobindo Pharma Latest Developments
Table 118. Zydus Cadila Details, Company Type, Gamma-aminobutyric Acid (GABA) Receptor Agonist Area Served and Its Competitors
Table 119. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
Table 120. Zydus Cadila Main Business
Table 121. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 122. Zydus Cadila Latest Developments
List of Figures
Figure 1. Gamma-aminobutyric Acid (GABA) Receptor Agonist Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Type in 2021
Figure 7. Gamma-aminobutyric Acid (GABA) Receptor Agonist in Hospitals
Figure 8. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Gamma-aminobutyric Acid (GABA) Receptor Agonist in Specialty Clinics
Figure 10. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market: Specialty Clinics (2017-2022) & ($ Millions)
Figure 11. Gamma-aminobutyric Acid (GABA) Receptor Agonist in Others
Figure 12. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Application in 2021
Figure 14. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Player in 2021
Figure 15. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2017-2022 ($ Millions)
Figure 17. APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2017-2022 ($ Millions)
Figure 18. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2017-2022 ($ Millions)
Figure 20. Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Value Market Share by Country in 2021
Figure 21. Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Consumption Market Share by Type in 2021
Figure 22. Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Application in 2021
Figure 23. United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Region in 2021
Figure 28. APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Application in 2021
Figure 29. China Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Country in 2021
Figure 36. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Type in 2021
Figure 37. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Application in 2021
Figure 38. Germany Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Market Share by Application in 2021
Figure 46. Egypt Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 52. APAC Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 53. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 55. United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 56. Canada Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 59. China Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 60. Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 61. Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 63. India Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 64. Australia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 65. Germany Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 66. France Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 67. UK Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 68. Italy Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 69. Russia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 70. Spain Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 73. Israel Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...